Abstract
Cancer treatment is a global challenge, and the incidence rates in Brazil are expected to increase by 68% by 2040. The best estimate of cancer treatment costs in Brazil (SUS and supplementary health) published in 2018 showed that systemic treatment (chemotherapy) was around R$8 billion. The high resistance rate to standard-of-care medications is a significant limitation in treating advanc…